IRIS
AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.512
NA - Nord America 1.110
EU - Europa 528
SA - Sud America 81
AF - Africa 12
OC - Oceania 8
Totale 7.251
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.719
US - Stati Uniti d'America 1.063
CN - Cina 465
HK - Hong Kong 222
GB - Regno Unito 142
IT - Italia 137
DE - Germania 73
BR - Brasile 67
FI - Finlandia 48
NL - Olanda 38
VN - Vietnam 34
CA - Canada 28
TR - Turchia 21
IN - India 20
MX - Messico 16
PL - Polonia 16
FR - Francia 14
CZ - Repubblica Ceca 10
JP - Giappone 10
LT - Lituania 10
UA - Ucraina 10
AU - Australia 8
ES - Italia 8
AT - Austria 6
AR - Argentina 4
BD - Bangladesh 4
ZA - Sudafrica 4
EC - Ecuador 3
ID - Indonesia 3
PE - Perù 3
RU - Federazione Russa 3
SE - Svezia 3
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
MY - Malesia 2
TL - Timor Orientale 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
CH - Svizzera 1
CO - Colombia 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
ML - Mali 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
VG - Isole Vergini Britanniche 1
YT - Mayotte 1
Totale 7.251
Salva come PNG Salva come JPEG
Città #
Singapore 325
Dallas 264
Hong Kong 217
Hefei 206
Ashburn 187
London 122
Boardman 115
Beijing 95
Shanghai 71
Council Bluffs 59
Munich 56
West Jordan 40
Los Angeles 37
Rome 35
Amsterdam 30
Turku 26
Santa Clara 24
San Francisco 23
Washington 23
Helsinki 22
Sona 20
Seattle 19
São Paulo 18
Bari 15
Ho Chi Minh City 15
Warsaw 15
Ankara 14
Toronto 13
Pune 12
Atlanta 10
Brno 10
Brooklyn 10
Mexico City 10
Tokyo 10
Boston 8
New York 8
Changsha 7
Charlotte 7
Chicago 5
Hanoi 5
Milan 5
Montreal 5
Chengdu 4
Chennai 4
Duino-Aurisina 4
Haikou 4
Haiphong 4
Naples 4
Noicattaro 4
Paris 4
State College 4
Brasília 3
Brest 3
Da Nang 3
Denver 3
Guayaquil 3
Johannesburg 3
Manchester 3
Philadelphia 3
Phoenix 3
Redmond 3
San Jose 3
Secaucus 3
Sydney 3
The Dalles 3
Vienna 3
Vilnius 3
Canberra 2
Central 2
Charleston 2
Cuernavaca 2
Curitiba 2
Dili 2
Guiyang 2
Handan 2
Herne Bay 2
Honolulu 2
Hải Dương 2
Lima 2
Linyi 2
Melbourne 2
Messina 2
Orem 2
Perugia 2
Reus 2
Ribeirão Preto 2
Rio de Janeiro 2
Rockville 2
Santo André 2
Stockholm 2
Tianjin 2
Topeka 2
Ajman 1
Almere Stad 1
Amman 1
Annapolis 1
Araguaína 1
Atibaia 1
Augusta 1
Baku 1
Totale 2.360
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 206
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 205
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 204
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 202
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 199
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 199
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 197
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 195
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 194
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 189
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 186
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 181
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 179
Leptin in immuno-rheumatological diseases 172
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 110
GH-resistance in different stages of chronic liver disease 109
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 106
Enhanced portal flow velocity and volume following Iloprost treatment 104
Diabetes in chronic liver disease: from old concepts to new evidence 104
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 101
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 100
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 98
Radiofrequency ablation of hepatic tissue: a new experimental animal model 97
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 97
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 95
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 95
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 95
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 94
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 92
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 89
Cannabinoids in Autoimmune and Rheumatic Diseases 87
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 87
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 87
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 87
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 85
Leptin in autoimmune mechanisms of systemic rheumatic diseases 85
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 84
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 82
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 82
ANA testing in ‘real life’ 82
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 78
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 73
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 73
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 68
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 66
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 65
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 63
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 57
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 54
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 49
Pain and Frailty in Hospitalized Older Adults 45
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 42
TNF-alpha and growth hormone resistance in patients with chronic liver disease 39
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 39
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 37
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 36
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 35
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 35
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 34
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 34
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 33
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 32
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 32
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 32
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 31
The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study 31
Matters of the heart: The case of TNF-alpha targeting drugs 31
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 31
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 30
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 30
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 30
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 30
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 30
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 29
Surgical complications after resection of adrenal carcinoma 29
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 29
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 28
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 27
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 27
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 27
Utility of ultrasound in the diagnosis of chronic worsened gout 26
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 26
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 26
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 26
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 25
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 25
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 25
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 25
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 25
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 25
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 24
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 24
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 23
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 23
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 23
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 22
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 22
Serum level of endostatin and digital ulcers in systemic sclerosis patients 22
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 22
Phase angle could be a marker of microvascular damage in systemic sclerosis 21
Totale 7.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.910
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/20261.091 324 193 331 243 0 0 0 0 0 0 0 0
Totale 7.317